Kolkata, India: A 35 year-old female was from the United States was blessed with a pregnancy after treatment at an Indira IVF clinic in Kolkata. Anna (name changed) and Saurabh (name changed, age 36) were trying to conceive through assisted reproductive technology (ART) for a long period in the States, but were only faced with unsuccessful outcomes. That changed when the couple travelled to India underwent ART treatment in the city’s Indira IVF clinic.
Anna and Saurabh had previously experienced three miscarriages with natural conception, followed by three unsuccessful IUI (intrauterine insemination) cycles performed in the US. These experiences had shattered their hopes of parenthood. However, they got convinced for travel to India on their friend’s recommendation as they heard of many positive outcomes in the country. At the Kolkata Indira IVF clinic, the couple initially underwent IVF (in vitro fertilisation) treatment with a biopsy process and achieved a positive pregnancy test in the first attempt. However, they unfortunately experienced a missed abortion at six weeks.
Faced with a case of unexplained infertility, the Indira IVF team, led by Sabina Yeasmin – Chief Embryologist at Indira IVF Kolkata, devised a personalised treatment plan. This incorporated Lymphocyte Immunisation Therapy (LIT), a specialised treatment for certain cases of unexplained recurrent pregnancy loss. Following LIT, the couple embarked on another full IVF cycle with embryo transfer. This time, their perseverance paid off, resulting in a positive pregnancy test and a currently ongoing healthy pregnancy.
Also Read | Emcure and Gennova to Resume mRNA Collaboration with HDT
Highlighting the developments India has made in its healthcare delivery in light of this case, Dr Kshitiz Murdia – CEO & Co-Founder of Indira IVF said, “At present, India has notched significant developments in its journey of providing exemplary medical treatments. This has made ripples world-over with people coming to our country to get treated for a number of diseases, including infertility. The medical tourism segment in India is expected to grow at a 17.20% CAGR from 2024 to 2034, surpassing US$ 50,670.5 million. We estimate that ART treatments will increase its share in medical tourism in the near future, especially with the establishment of regulatory mechanism and implementation of stringent legislation.”
Speaking about the case, Sabina Yeasmin – Chief Embryologist at Indira IVF Kolkata said, “Cases such as Anna and Saurabh’s where there have been multiple pregnancy failures – both naturally and after treatment – can be emotionally draining. Our focus in such scenarios is to provide comprehensive care and exploring all avenues to get to the bottom of the cause of infertility. Finally, the couple was able to conceive with the help of the team’s personalised approach in sync with our cutting-edge technology.”
About Indira IVF
Indira IVF is India’s largest network of infertility treatment hospitals with 130-plus centres across the country, supported by a passionate workforce of over 2,700 people. Indira IVF has performed about 40,000+ IVF procedures in a year – the highest number in the country.
As a responsible leader, Indira IVF constantly strives to dispel the stigma, taboo, myths and misinformation about infertility. Indira IVF is also committed to developing and grooming talent for fertility treatments. Through the Indira Fertility Academy it collaborates with like-minded organisations and institutions to further this cause.
Indira IVF was founded in the year 2011 in Udaipur, Rajasthan by Dr Ajay Murdia.
For more information log onto https://www.indiraivf.com/
